Similar articles

• [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].

  Rachev E. Rachev E. Akush Ginekol (Sofiia). 1994;33(3):45-7. Akush Ginekol (Sofiia). 1994. PMID: 7793531 Bulgarian.
• A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study Group.

  al-Azzawi F, Van der Mooren MJ, Rolland R, Hirvonen E. al-Azzawi F, et al. Br J Clin Pract. 1997 Jan-Feb;51(1):20-3, 25-6. Br J Clin Pract. 1997. PMID: 9158267 Clinical Trial.
• Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese.

  Chen GS, Zhang MY, Wang Q, Ye JC. Chen GS, et al. Zhongguo Yao Li Xue Bao. 1996 Sep;17(5):407-10. Zhongguo Yao Li Xue Bao. 1996. PMID: 9863160
• Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetes risk.

  Godsland IF, Stevenson JC. Godsland IF, et al. Br J Clin Pract Suppl. 1996 Sep;86:1-5. Br J Clin Pract Suppl. 1996. PMID: 8995002 Review. No abstract available.
• [Oestrogel--a transdermal and convenient method of hormone replacement therapy].

  Krumov G. Krumov G. Akush Ginekol (Sofiia). 2003;42 Suppl 1:17-20. Akush Ginekol (Sofiia). 2003. PMID: 12858498 Review. Bulgarian. No abstract available.